Source: Business Wire

Press Release: Innoviva : Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference

BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on

Read full article »
Annual Revenue
$100-500M
Employees
100-250
CEO Avatar

CEO

Pavel Raifeld

CEO Approval Rating

90/100

Read more